The regulation of cell cycle progression and differentiation in retinal progenitor cells is a fundamental feature controlling organ size of the eye in vertebrates. Nance-Horan Syndrome (NHS) is a rare X-linked disorder caused by mutations in the NHS gene. Dysmorphic features of NHS include severe congenital cataracts, micropthalmia, facial dysmorphisms, and visual impairment. In this study we report an evolutionarily conserved role for NHS in vertebrate retinogenesis. Loss of function of nhs leads to small eye size in both zebrafish and Xenopus tropicalis, marked by reduced proliferation but not cell death. Transcriptome analysis of nhs morphant zebrafish eyes revealed a marked upregulation in Δ113p53, an isoform of p53, concomitant with a selective upregulation of p53 responsive genes that inhibit cell cycle progression but not apoptosis. Our data supports a model where Nhs is a negative regulator of Δ113p53 expression and exerts its function through regulation of the p53 pathway to promote expansive growth of retinal progenitor cells prior to differentiation.
Introduction:
A fundamental question in biology is how organ size is controlled during development. Organogenesis is regulated by a balance between progenitor cell cycle progression, self-renewal, differentiation, and programmed cell death. The neural retina serves as a model system that illustrates this general concept. The retina develops as an outpouching of the neuroepithelium and grows through symmetric proliferative divisions of retinal progenitor cells (RPCs) followed by a switch to asymmetric neurogenic divisions (Fadool and Dowling 2008; Willardsen and Link 2011; He et al. 2012; Boije et al. 2014 ). In the zebrafish retina, early RPCs undergoing symmetric cell divisions progress through the cell cycle slowly but then switch to a rapidly proliferating phase in which the cell cycle duration markedly decreases (Hu and Easter 1999; Li et al. 2000; He et al. 2012) . This serves to rapidly increase the progenitor pool in advance of asymmetric neurogenic divisions in which some daughter cells exit the cell cycle to differentiate into neurons (He et al. 2012) . Thus, coordinated cell proliferation and differentiation result in the correct number of cells that collectively contribute to the volume and size of the retina (Joseph and Hermanson 2010; Hindley and Philpott 2012) . However, the molecular mechanisms that regulate cell cycle progression in retinal progenitor cells are not completely understood (He et al. 2012; Boije et al. 2014 ).
Nance-Horan Syndrome (NHS) is an X-linked developmental disorder characterized by severe congenital cataracts, dental anomalies, dysmorphic facial features and mental retardation (Brooks et al. 2004; Ramprasad et al. 2005; Coccia et al. 2009 ). Additional features of the disease include micropthalmia and microcornea (Florijn et al. 2006; Huang et al. 2007) . NHS is caused by mutations in the NHS gene found at the distal end of the X chromosome. The most frequent mutations associated with NHS are nonsense mutations predicted to result in a truncated protein (Burdon et al. 2003; Ramprasad et al. 2005; Florijn et al. 2006; Huang et al. 2007; Sharma et al. 2008; Coccia et al. 2009; Chograni et al. 2011; Tug et al. 2013; Hong et al. 2014; Shoshany et al. 2017; Tian et al. 2017 ), but insertions, small deletions, and a missense mutations have also been reported (Accogli et al., 2017; Brooks et al., 2004; Burdon et al., 2003; Chograni et al., 2011; Florijn et al., 2006; Li et al., 2015) . Affected males have severe bilateral congenital dense nuclear cataracts that lead to profound vision loss and usually require surgery at an early age (Burdon et al. 2003; Huang et al. 2007; Sharma et al. 2008; Coccia et al. 2009 ). Despite cataract surgery during infancy, many NHS patients continue to exhibit visual impairment that may be caused by an underlying retinopathy (Mathys et al. 2007; Ding et al. 2009 ). It has been demonstrated that NHS protein is expressed in midbrain, lens, tooth and retina (Burdon et al. 2003; Sharma et al. 2006 ).
The p53 tumor suppressor protein has an established role as a cellular stress sensor, responding to a variety of insults such as DNA damage, nutrient starvation, nucleolar and ribosomal stress, and hypoxia (Vousden and Lane 2007; McCubrey et al. 2017 ). Evidence suggests that p53 functions to arrest cell cycle progression allowing time for DNA repair machineries to restore genome integrity before replication. If deleterious conditions are too severe, p53 activates cell death pathways. p53 performs many of its functions though downstream transcriptional activation of target genes, such as cdkn1a/p21 CIP1/WAF1 (p21) to halt cell cycle at the G1 phase and bax to execute programmed cell death pathways (Vogelstein et al. 2000; Harris and Levine 2005) .
In addition to the full-length p53 protein, the p53 gene locus encodes for several isoforms generated by alternative promoter usage or alternative spicing (Bourdon et al. 2005; Joruiz and Bourdon 2016) . A prominent variant Δ133p53 in humans is transcribed from an internal promoter in intron 4 and is evolutionarily conserved in zebrafish (termed Δ113p53), suggesting an important role in p53 functions (Bourdon et al. 2005; . Δ113p53 encodes an N-terminally truncated protein with a deletion of the transactivation domains and a partial deletion of the DNA-binding domain (Bourdon et al. 2005; Chen and Peng 2009) . ∆113p53 is itself a p53 target gene that is strongly upregulated following DNA damage, due to binding of full-length p53 to p53 response elements within intron4 of the p53 locus (Bourdon et al. 2005; Marcel et al. 2010; Aoubala et al. 2011) . Previous work showed that ∆113p53 functions to protect cells from apoptosis by differentially modulating p53 response genes, promoting the expression of cell cycle arrest genes while antagonizing p53regulated apoptotic activity Aoubala et al. 2011; Ou et al. 2014) .
Thus, the ∆113p53/∆133p53 variants function evolutionarily to promote cell survival when genome integrity is compromised to allow for DNA repair to take place (Gong et al. 2015) .
Although p53 has a well-established role in maintaining genome stability to prevent tumor progression, a role for the p53 pathway in regulating development and organogenesis is less well understood. Loss-of-function mutations in p53 at first appeared to result mostly in viable offspring with no obvious developmental defects (Donehower et al. 1992 ). However, a number of p53 mutant mice die in utero due to exencephaly, a defect in neural tube closure due to overgrowth of neural progenitors in the midbrain, due at least in part to decreased apoptosis of neural progenitors (Sah et al., 1995) . On the other hand, unrestrained activity of p53 can inappropriately induce p53 target genes and trigger cell cycle arrest and/or cell death during development (Jacobs et al. 2004; Dugani et al. 2009 ). For instance, loss of mdm2 or mdm4, negative regulators of the p53 protein, cause early embryonic lethality in a p53-dependent manner (Marine et al. 2006 ). More modest levels of p53 activation are associated with defects similar to those seen in patients with CHARGE syndrome (Van Nostrand et al. 2014) . Recent work in zebrafish identified digestive organ expansion factor (def) as a pan-endodermal-enriched factor that is essential for expansive growth of digestive organs . Analysis of def null mutants revealed a selective regulation of the p53 isoform Δ113p53, that contributed to cell cycle arrest leading to reduced size and defective digestive organ development ).
Here, we report a role for NHS in the development of the vertebrate retina.
Knockdown of nhs in zebrafish and frog resulted in a reduced eye size. We show the small retinal size caused by nhs deficiency is due a decrease in RPC proliferation. The small retina, caused by nhs deficiency, is due a proliferation restriction mediated by the elevated expression of Δ113p53. We hypothesize that nhs functions in RPCs to limit p53 pathway induction as neural progenitors undergo rapid cell division.
RESULTS

The NHS family of genes
The Nance-Horan Syndrome family of genes is conserved among vertebrates including humans, mice, frogs, and zebrafish. Members of the NHS gene family include the prototypical NHS, as well as NHS-like 1 (NHSL1) and NHS-like 2 (NHSL2). The NHS genes are orthologs of the Drosophila gene GUK-holder (gukh) (Katoh and Katoh 2004) (Fig. 1A) . Although most vertebrates express three NHS paralogs, (NHS, NHSL1 and NHSL2), zebrafish have two copies of each paralog (nhsa, nhsb, nhsl1a, nhsl1b, nhsl2a , and nhsl2b) due to a genome duplication event in the teleost lineage (Postlethwait et al. 1998 (Postlethwait et al. , 2000 (Fig. 1A) .
In this study, we focused only on NHS orthologs. Previously, it was noted that the human NHS gene encompassed an unusually long distance between exon1 and exon2 (Brooks et al. 2004 (Brooks et al. , 2010b . Comparison of other vertebrate genomes showed that the genomic architecture of the NHS gene remained conserved among human, mouse, frog and zebrafish with comparable number of exons. The large distance between exon1 and exon2 of NHS was also detected in other vertebrate genomes (Fig. 1B) . The human NHS gene generates multiple protein isoforms by virtue of alternative promoter usage and alternative splicing (Huang et al. 2006; Brooks et al. 2010a ). Isoforms arising from the alternative translational start site in exon1a appear to be evolutionarily conserved across vertebrates, as evidenced by sequencing of expressed sequence tags (EST) libraries ( Fig. 1B) . However, only NHS isoforms encoded from the first translational start site in exon1 are predicted to be essential for development, since nonsense mutations in exon1 in humans leads to NHS (Burdon et al. 2003; Brooks et al. 2004) .
We examined the temporal expression pattern of nhs paralogs during zebrafish development and find that both nhsa and nhsb are present in embryos before 2 hours post fertilization (hpf), suggesting that both transcripts are loaded maternally (Fig. 1C ).
We find that both nhs paralogs are expressed through all stages of development ( Fig.   1C ).
Zebrafish nhsb is expressed in the developing eye and is required for normal retinogenesis
To determine the role of NHS in zebrafish development, we first examined the nhsa fh298 mutants generated by Tilling (Draper et al. 2004) . nhsa fh298 carries a truncating nonsense mutation at position Q217* (C4524T) ( Fig. 1B ). Examination of embryos derived from an incross of nhsa fh298/+ heterozygotes revealed no discernable morphological differences among siblings, suggesting that nhsa is dispensable for early development (Fig. S1 ).
We therefore decided to focus our efforts on zebrafish nhsb during embryogenesis. Using in situ hybridization, we found expression of nhsb in the eye during key stages of retinogenesis. Expression of nhsb was seen within proliferating retinal progenitor cells (RPCs) and in the lens at 24 hpf ( Fig. 2A ). By 48 hpf and 72 hpf, We next examined a role for nhsb in zebrafish embryo development. To accomplish this, we designed splice-blocking antisense morpholino oligonucleotides (MO) to the exon2-intron2 boundary of the nhsb gene (nhsb MO1) ( Fig. 1B ). We found that nhsb MO1-injected embryos initially look indistinguishable from control embryos until 24 hpf, suggesting that knockdown of nhsb does not affect early development, eye field specification and/or separation. By 72 hpf, we observed a striking difference in the size and shape of the retina in nhsb morphants as compared to controls ( Fig. 2E-H) .
nhsb morphants exhibited a small retina located on top of the lens (Fig. 2H ). We did not observe any lens defects in nhsb MO1-injected embryos that were reminiscent of cataracts as observed in humans with Nance-Horan Syndrome (Burdon et al. 2003; Brooks et al. 2004; Sharma et al. 2008; Coccia et al. 2009 ). We confirmed that injection of nhsb MO1 caused a mis-splicing of the nhsb transcript leading to retention of intron2 ( Fig. S2 ). To ensure that the small eye phenotype was specific to knockdown of nhsb, we injected a second splice-blocking nhsb MO (nhsb MO2), targeted to the intron2-exon3 (I2E3) boundary ( Fig. 1B) . We found that nhsb MO2-injected embryos exhibited the same phenotype as that observed with nhsb MO1 (hereafter referred to as nhsb MO) ( Fig. S3 ).
To further test whether the small eye phenotype was specific to disruptions in the nhsb gene, we used CRIPSR/Cas9 to generate insertion/deletion (indel) mutations at the nhsb locus. We designed a single-stranded guide RNA (gRNA) to target exon1 of the nhsb gene ( Fig 1B) . It was previously reported that injection of increasing amounts of gRNA can lead to bi-allelic disruptions in the targeted gene (Jao et al. 2013) . We found that co-injection of nhsb ex1 gRNA and Cas9 mRNA into one-cell stage embryos led to growth defects in the eye of injected founder (F0) embryos (14%, n = 245), similar to that seen in nhsb morphants (Fig 2I,J) . We chose five injected embryos displaying the small eye phenotype and validated indel mutations at the nhsb locus using a T7 endonuclease I (T7E1) assay; all assayed embryos showed high mutagenesis rates at the nhsb locus ( Fig. S4 ). Taken together, our results demonstrate that the nhsb gene is expressed in the retina during key stages of retinogenesis, and that loss-of-function of nhsb leads to reduced retinal size in zebrafish.
Expression and function of NHS is conserved in Xenopus tropicalis
To test whether gene expression was conserved in other vertebrates, we examined a role for nhs in retina development in Xenopus tropicalis. We chose X. tropicalis because they are diploid and possess only one nhs gene. First, we made antisense in situ hybridization probes against the Xenopus tropicalis nhs gene ( Fig. 1B ).
Similar to zebrafish nhsb, the expression of nhs was detected in the retinal progenitor cells and lens of Xenopus tropicalis eyes at embryonic stage 31 ( Fig. 3A) . As retinogenesis proceeded, nhs expression in RPCs faded and was found concentrated in the plexiform layers of the retina (Fig. 3A-D) .
To determine whether the role of Nhs in retina development was evolutionarily conserved among vertebrates, we designed splice-blocking MOs targeting the exon3-intron3 boundary of Xenopus tropicalis nhs (nhs MO). We co-injected nhs MO along with rhodamine-dextran into one cell of a two-cell stage embryo. This experimental approach provided us with an internal control, since only half the embryo received nhs MO. We found that 96% of embryos (n = 56) injected with nhs MO had small retinas as compared to eyes on the contralateral side that did not receive morpholino ( Fig. 3E-H) . 
Nhs is required for proliferative growth of RPCs in the retina.
To further investigate the function of Nhs in retinal development we performed the rest of our analysis on zebrafish nhsb morphants. The earliest manifestation of the reduced eye size in nhsb morphants occurred between 24hpf -48 hpf. This corresponds to the period of rapid RPC proliferation followed by neurogenesis and differentiation (He et al. 2012) . To determine whether the reduced eye size was due to an increase in RPC cell death, we analyzed wild-type and nhsb morphant retinas for apoptotic cells. We evaluated cell death using an anti-cleaved caspase-3 antibody, a marker of apopotic cell death. We found virtually no dying cells in the retinas of either wild-type (0.187% (4/2137 cells, n = 6 embryos) or nhsb-deficient embryos (0.140%; 2/1427 cells, n = 6 embryos) at 36 hpf (Fig. 4A,B ). Furthermore, nhsb morphant retinas did not display pyknotic morphology characteristic of dying cells (Fig. 4A,B) . These results imply that the reduced eye size observed in nhsb-depleted embryos was not due to an increase in cell death.
To determine whether the small eye phenotype observed in nhsb morphants was due to a defect in RPC proliferation, we analyzed cryosections stained with phosphohistone 3 (PH3) antibody, a marker of M-phase of the cell cycle. At 24 hpf, a timepoint in which no morphological difference in eye size was observed, we found no significant difference in the proportion of PH3-positive cells in nhsb morphants compared to wildtype embryos (wt, 0.43 ± 0.05%, n = 538 cells, 4 embryos; nhsb MO, 0.51 ± 0.04%, n =745 cells, 5 embryos)( Fig. 4B-I) . At 48 hpf, however, the number of cells at M-phase was significantly fewer in the retina of nhsb morphants (0.92 ± 0.08%, n = 655 cells, 4 embryos) compared to wild-type (1.98 ± 0.18%, n = 2218 cells, 4 embryos) embryos (p < 0.05)( Fig. 4B-I ). This suggests that reduced proliferation of RPCs may contribute to the lack of eye growth in the absence of nhsb function.
We next sought to determine whether differentiation of RPCs into neurons was affected by loss of nhsb. To accomplish this, we made use of TgBAC(neurod1:EGFP) transgenic zebrafish that expresses GFP under control of the promoter for neuroD (Thomas et al. 2012 ). This transgene is not expressed in proliferating RPCs, but is expressed in a subset of retinal neurons undergoing differentiation (Thomas et al. 2012 ). Some of the first differentiating neurons identified with this transgenic line can be seen around 34 hpf ( Fig. 5A-C) . Many GFP-positive neurons are present in the retina of wild-type embryos at this timepoint, and this number increased by 48 hpf (Fig. 4G-I) . In contrast, by 34 hpf, no GFP-positive neurons are observed in nhsb morphants ( Fig. 4D-F ). By 48 hpf, however, a few GFP-expressing neurons can be visualized in nhsb morphant retinas ( Fig. 4J-L) , suggesting that the differentiation of neurons from RPCs is not blocked but is delayed in nhsb-depleted embryos. These findings are consistent with the idea that nhsb knockdown mainly affects expansive growth of RPCs but does not inhibit neuronal differentiation.
Loss of nhsb leads to a marked upregulation of Δ113p53 and p21, but not fulllength p53
To gain insight into the downstream function of Nhsb, we compared retinal expression profiles between wild-type and nhsb morphants. Total RNA was isolated from 40 zebrafish eyes dissected from wild-type and nhsb morphant embryos at 48 hpf for microarray analysis using Affymetrix zebrafish GeneChips. We used SAM analysis and found 1,212 significant genes that were differentially expressed in wild-type eyes compared to nhsb morphant eyes (Table S2A,B).
A subset of genes with significantly higher expression in nhsb-depleted eyes included genes that are markers of RPC identity such as mz98/col15a1b (collagen typeXV, alpha 1b), ccnd1 (cyclin D1), dlc (deltaC), and pold1 (DNA polymerase delta 1).
( Fig. 6A) . We also found a subset of genes whose expression was reduced in nhsb morphants compared to control, including markers of differentiated neurons such as neuroD, opn1sw1 (opsin1 short-wave-sensitive 1), rho (rhodopsin), calb2a
(calbindin2a), snap25a (synaptosomal-associated protein, 25a) (Fig. 6A ). These findings are consistent with the idea that RPCs in nhsb morphant retinas proliferate slower, maintaining their identity as RPCs with delayed neuronal differentiation.
Surprisingly, functional annotation analysis using the Database for Annotation, Visualization and Integrated Discovery (DAVID) identified a number of genes that were differentially expressed between wild-type and nhsb-depleted retinas with known roles in the regulation of cell cycle progression, including the tumor-suppressor gene tp53
and its target gene mdm2 (Fig. 6A ). This suggests that loss of nhsb may regulate cell cycle progression through the p53 pathway.
To validate our microarray results, we performed semi-quantitative RT-PCR, using RNA extracted from dissected retinas of wild-type and nhsb morphants. We found that the levels of full-length p53 transcripts were unchanged in nhsb morphants compared to wildtype controls, a result that differed from our microarray expression analysis (Fig. 6B ). Whereas the microarray probe binds to the C-terminal tp53 coding region, our RT-PCR primers amplify N-terminal tp53 coding region from exon1 to exon4 (Table S1 ). However, using primers that specifically amplify the truncated Δ113p53 transcript, we found a marked up-regulation of Δ113p53 expression in nhsb morphant eyes compared to wild-type controls (Fig. 6B ). Our results demonstrate that the elevated p53 transcripts detected by the Affymetrix probe, directed against the Cterminal coding region of p53, is due to the upregulation of the N-terminal truncated p53
variant Δ113p53, but not full-length p53.
We next asked whether other p53 target genes were affected by nhsb depletion.
Semi-quantitative RT-PCR results showed that additional p53 target genes were upregulated in nhsb morphant eyes compared to wild-type eyes, including mdm2, ccng1 (cyclinG1), and cdkn1a/p21 WAF1/CIP-1 (p21), a cyclin dependent kinase inhibitor that blocks the G1-to-S-phase transition (Cazzalini et al. 2010) (Fig. 5B ). On the other hand, expression levels of the pro-apoptotic factor bax did not show apparent differences between nhsb morphants and control eyes (Fig. 5B ). Taken together, these data are consistent with our histological data that the reduced eye size in nhsb morphants is not caused by increased apoptosis but rather is due to a proliferation restriction imposed on RPCs by elevated expression of the p53-target gene and cell-cycle checkpoint protein, p21.
Knockdown of p53, reduces Δ113p53 and p21, and rescues the nhsb morphant phenotype
Previous data from Chen and colleagues demonstrated that the induction of
Δ113p53 was p53-dependent ). Our data suggest that nhsb may be a negative regulator of Δ113p53 expression. Since Δ113p53 is itself a transcriptional target of full-length p53 that binds to promoter elements in intron 4 ), we reasoned that the small-eye phenotype seen in nhsb morphants may be rescued by knock-down of full-length p53. To determine whether full-length p53 is required for the elevated levels of Δ113p53 caused by nhsb depletion, we co-injected nhsb MO2 with p53 MO ATG that specifically targets the translation start site of the full-length p53 protein (Robu et al. 2007 ). We found that co-injection of nhsb MO and p53 MO ATG rescued the small eye phenotype caused by injection of nhsb MO alone. (Fig. 7A ). Splice blocking efficiency and knockdown of nhsb was confirmed by RT-PCR ( Fig. S6 ) and phenotypes quantified ( Fig. S7) . Interestingly, co-injection of nhsb MO and p53 MO ATG led to a reduced expression of Δ113p53 and p21 transcripts, compared to nhsb MO alone (Fig.   6B ). Our findings indicate that the upregulation of Δ113p53 and p21 in nhsb-depleted retina is dependent on full length p53, consistent with the notion that Δ113p53 and p21 are p53 target genes ). Overall this result suggests that the proliferation restriction enforced on RPCs was alleviated when levels of Δ113p53 and p21 were reduced.
It was previously reported that Δ113p53 antagonizes the apoptotic activities of Although it is clear that the p53 tumor suppressor plays important roles in cancer progression, a role for p53 (or any or the p53 isoforms) in embryonic development or development of the nervous system is less clear. p53 acts primarily as a transcription factor, although it has been shown to have a cytoplasmic roles (Vousden 2006; Endo et al. 2008) . In response to DNA damage or other cellular stresses, there are two main outcomes of p53 activation, namely cell cycle arrest or apoptosis. In the nervous system, p53 plays a key role, along with other p53 family members, p63 and p73, in regulating survival and apoptosis in the developing and adult nervous system (Miller et al. 2000; Jacobs et al. 2004 ). p53 becomes a major pro-apoptotic proteins eliciting naturally occurring cell death in peripheral neurons (Aloyz et al. 1998; Jacobs et al. 2005 )and neural progenitor cells (Dugani et al. 2009; Fatt et al. 2014) . Consistent with this, mice deficient in DNA ligase 4 (Lig4) or XRCC4, two components of the nonhomologous end-joining (NHEJ) pathway that repairs double-stranded DNA breaks, exhibit neuronal apoptosis that has been shown to be p53-dependent Gao et al. 1998) . A screen of zebrafish mutants harboring mutations various categories of cell essential genes, such as DNA replication, transcription, telomere maintenance, ribosome biogenesis, splicing, chaperoning, endocytosis, and cellular transport, all share an upregulation of p53 and excessive neural apoptosis (Danilova et al. 2010) . Activation of the p53 pathway then is likely responsible for a wide range of defects seen in human congenital disorders (Mendrysa et al. 2011) .
Few studies, however, have investigated the role of p53 isoforms, such as Δ113p53/Δ113p53, in embryonic development. The zebrafish protein Δ113p53, and its human counterpart, Δ133p53, are N-terminally truncated forms of p53 that are missing the transactivation domain, and MDM2-interacting motif, with a partial deletion of the DNA-binding domain (Bourdon et al. 2005; ). Transcriptional expression of Δ113p53/Δ133p53 is initiated by an alternative p53 promoter in intron 4 that is completely dependent on full length p53 protein (Bourdon et al. 2005; Aoubala et al. 2011) . Δ113p53/Δ133p53 is strongly induced by DNA double strand breaks, where it antagonizes p53-mediated apoptosis (Gong et al. 2015) .
Previous work had shown that Δ113p53 does not act in a dominant-negative fashion, but by differentially modulating p53 target gene activation to protect cells from apoptosis Ou et al. 2014) . In zebrafish, Δ113p53 was identified in the analysis of a zebrafish mutant def, a pan-endodermal-enriched factor that is essential for the expansive growth of digestive organs . In def null mutants, Δ113p53
transcripts were upregulated and induced the expression of p53-responsive genes to trigger arrest of cell cycle, but not apoptosis, leading to reduced organ growth . We identified a similar role for nhsb in expansion growth of the retina. In the absence of nhsb, Δ113p53 expression increased, which concomitant increase of the p53 target gene p21. Increased levels of p21 enforced a proliferation restriction on RPCs, while the pro-apoptotic gene bax was not increased in hypoplastic retinas. Our findings are in agreement with the previously reported role for Δ113p53 as regulator of p21, but not bax ). These results suggest that i) Nhs is required in retinal progenitor cells to keep levels of Δ113p53 low, and that ii) loss of nhs causes a small retina due to cell cycle arrest, but not apoptosis. Indeed, when Δ113p53 were depleted, loss of nhsb led to an increase in cell death. One possibility is that Nhs regulates the steady state levels of p53 protein, and in the absence of Nhs, p53 levels would accumulate and elevate expression of Δ113p53 and p21. Alternatively, Nhs could limit the transcriptional activity of p53 without affecting protein levels. It was recently reported that Def is a nucleolar protein that mediates p53 protein degradation through a proteasome-independent pathway (Tao et al. 2013) .
Future studies will be aimed at uncovering the mechanism of how Nhs modulates the p53 pathway.
Finally, our study uncovers a developmental role for Nhs that provides an underlying mechanism for pathology associated with Nance-Horan Syndrome (NHS).
Affected males have severe bilateral congenital dense nuclear cataracts that lead to profound vision loss and usually require surgery at an early age (Burdon et al. 2003; Huang et al. 2007; Sharma et al. 2008; Coccia et al. 2009 ). Despite cataract surgery during infancy, many NHS patients continue to exhibit visual impairment that may be caused by an underlying retinopathy (Mathys et al. 2007; Ding et al. 2009 ). Our findings that Nhs is essential for proper retinal development may clarify why NHS patients continue to exhibit ocular abnormalities and vision loss, even when cataracts have been corrected by surgery. NHS is caused predominantly by truncating (nonsense) mutations in the NHS gene that have been found in each of the 8 exons. There is no apparent clinical difference between mutations in C-terminal exons compared to N-terminal exons (Tug et al. 2013) . Previous reports have suggested that humans have at least three isoforms of NHS transcripts generated by the use of alternative transcriptional start sites, arising from exon1, exon1a, and exon1b (see Fig 1B) . Transcripts encoded from exon1 is known to be important in the pathogenesis of NHS, because patient nonsense mutations identified in exon1 are only predicted to affect this isoform (Burdon et al. 2003; Brooks et al. 2004; Huang et al. 2006; Hong et al. 2014 ). This exon1 is evolutionarily conserved in vertebrates. Our results presented here using CRISPR genome editing with guide RNAs directed against exon1 of the zebrafish nhsb gene showed a similar micropthalmia compared with morpholino oligonucleotide-mediated knockdown. These results are consistent with the human molecular genetics demonstrating that NHS isoforms encoded from exon1 are relevant to the pathogenesis of Nance-Horan Syndrome.
Zebrafish and Xenopus tropicalis Husbandry
Zebrafish (Danio rerio) were maintained according to standard procedures and staged as previously described (Kimmel et al. 1995) . The nhsa fh298 mutant line carries a truncating nonsense mutation at position Q217* and was generated by TILLING (Draper et al. 2004 ). (Obholzer et al. 2008) . Xenopus tropicalis embryos were obtained and cultured using standard methods (Sive et al. 2000) .
Phlyogenetic analysis
Coding DNA sequences were gathered from, Ensembl 
Whole-mount in situ hybridization
RNA in situ hybridization was carried out as previously described (Walsh et al., 2011) .
The gene specific probe fragments to the 3'UTR region of nhs genes were obtained by PCR (see Table S1 for primer pairs) from cDNA of 24 hpf zebrafish wild type embryos or early-stage X. tropicalis embryos. PCR products were cloned into pCR4-Blunt, sequenced. Sense and antisense riboprobes were transcribed from linearized plasmids and labeled with digoxigenin (DIG RNA-labelling reagents, Roche Biochemicals).
Primers used to amplify zebrafish nhsb were 5' tgatctaccttttctcccatgccatt 3' and 5' tctcacacaccacagaggctcca 3'. Primers used to amplify Xenopus tropicalis nhs were 5' tgccagcccacattgattatag 3' and 5' ccttaaaaagcaggccacagtt 3'.
Morpholino injections
Antisense MOs were injected at the 1-cell stage in zebrafish embryos and into one cell of a two-cell stage Xenopus embryo. Microinjections of antisense MOs were carried out using an Eppendorf microinjector and Zeiss stereoscope, as described (Dickinson and Sive, 2009 ). Morpholinos were supplied by Gene Tools and were as follows:
zebrafish nhsb: MO1 E2I2 5'CCAGAAGACCCATCAGTACCTCTGT3', 4 ng, MO2 I2E3 5' CTGCTGCTGGTCTGTGAAGCAAACA 3', 3.5 ng, Xenopus tropicalis nhs: MO E3I3 5' GTGTGTAATATATCTTACCTCTCCG 3', 8.5 ng. The p53 MO ATG targets the translation start site of full-length p53 as described (Robu et al. 2007 ):
5'GCGCCATTGCTTTGCAAGAATTG 3', 3 ng. A morpholino that targets the splice junction from exon ES to intron 4 of p53 and disrupts splicing of Δ113p53 isoform while leaving full-length p53 intact: splMO 5' TGTCTTTTCAAATGTCTTACCCTCC 3', 3 ng.
CRISPR Design and injection
We designed guide RNA (gRNA) sequence directed against exon1 of nhsb (5' GGTCCGGGATAGAGCCACAT 3'). For making gRNA, the guide sequence template was generated by annealing and filling-in two oligonucleotides: guide oligo ( XbaI, phenol-chloroform extracted followed by ethanol precipitation. Capped nls-zCas9nls mRNA was synthesized using mMessage T3 kit (Invitrogen) and purified using Illustra Probe-quant columns (GE Healthcare). The mix of gRNA (100ng/μL) and nls-zCas9-nls mRNA (300 ng/μL) was injected into one-cell stage embryos.
T7 Endonuclease I Assay
Genomic DNA was prepared from whole embryos at 24 hpf. A short stretch of genomic region (~735 bp) flanking the target site was PCR amplified from genomic DNA. PCR product was denatured and slowly allowed to re-anneal to encourage heteroduplex formation. The re-annealing procedure consisted of a 5 minute denaturation step, followed by cooling to 85°C at -2°C per second and further to 25°C at a rate of -0.1°C per second. The re-annealed amplicon was then digested with 20 units of T7 endonuclease I (New England Biolabs) at 37°C for 15 minutes. The reaction was stopped by adding 1 μL of 0.5M EDTA. The sample was run through a 2% agarose gel and visualized by ethidium bromide staining.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
Splice-blocking MOs were validated by RT-PCR. Primers used to validate are listed in Supplementary Table 1 . Briefly, total RNA was isolated from whole embryos using an RNeasy kit (Qiagen) and genomic contamination was eliminated by on-column DNA digestion (Qiagen). First Strand cDNA was synthesized using the Protoscript M-MuLV First-Strand cDNA Synthesis Kit (New England Biolabs). Equal concentrations of RNA (1ug) from all developmental timepoints were used in the cDNA synthesis reaction.
Concentration of cDNA across developmental timepoints was validated using primers specific to the ornithine decarboxylase (ODC) gene or elf1a. RNA extracted from retinas were used to validate array data. For semiquantitative RT-PCR, the amount of template and the number of PCR cycles were optimized to ensure that the reactions were in the linear range of amplification. The primer pairs and detailed PCR conditions used to amplify each of these genes are listed in Table S1 .
Affymetrix Array
We dissected 40 eyes each from wildtype or nhsb MO2-injected embryos at 48hpf. This experiment was performed in duplicate. Dissections were done in Half Ringers Solution (2.2mM CaCl2, 5.6mM KCl, 154 mM NaCl, 2.4mM NaHCO3, 2 mM Tris-Cl, adjust to pH 7.4) on ice. Total RNA was extracted from pooled tissues using RNeasy kit (Qiagen) and treated with DNAse I. We used 200ng input total RNA for cRNA amplification using the Affymetrix One Cycle kit. Amplicons were fragmented, hybridized to GeneChip Zebrafish Genome Arrays and scanned (Affymetrix). Quality control of total RNA, amplified RNA, and fragmented RNA was checked using Experion (Bio-Rad). GeneChip arrays were scanned on an Affymetrix Scanner 3000 7G scanner. Data was analyzed by Affymetrix Expression Console software. Raw intensity data was exported and filtered with a lower cut off value of 2 to assure that probe intensities data were generated within the dynamic range of fluorescence. Data was normalized by Robust Multi-array Average (RMA) analysis to account for a possible probe effect, and uploaded into TMEV for Significance Analysis of Microarrays (SAM) analysis. The resulting 1,212 significant genes were entered into DAVID for further gene ontology analysis.
Immunostaining and Imaging
Embryos were fixed in 4% PFA overnight at 4°C, incubated in 30% sucrose and saturated in OCT (Tissue-Tec), frozen on cryostat stages prior to storage at -20°C.
Coronal sections of 10uM were cut on a cryostat and mounted to Colorfrost Plus, microscope slides (Fisher). Immunostaining was performed on sections with the following antibodies: anti-phosphohistone 3 (pH3) (1:1000 Cell Signaling); anti-GFP
(1:2000, Torrey Pines); cleaved caspase 3 (1:500) (Cell Signaling). Primary antibodies were detected using secondary antibodies: goat anti-mouse Alexa 564 or goat antirabbit Alexa 488 (Life Technologies). Nuclei were labeled with Dapi. Sections were mounted in 100% glycerol and coverslipped. Confocal images of labeled cryostat sections or whole-mount embryos were obtained on a Carl Zeiss Spinning Disk Laser Confocal Observer Z1 (VCU) using either 20X or 63X objectives.
